Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.
Related Articles
Gene Therapy Trial at the Retina Foundation of the Southwest featured in The Dallas Morning News Gene Therapy Trial for Choroideremia The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust grants Retina Foundation $133,000 for Genetic Eye Disease Rose-Silverthorne Retinal Degenerations Lab to Conduct Natural History Study of Usher Syndrome George and Laura Bush to headline Retina Foundation benefit in March